相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Screening for prostate cancer: an updated Cochrane systematic review
Dragan Ilic et al.
BJU INTERNATIONAL (2011)
Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: A single-institution experience of 356 patients
Geert M. Villeirs et al.
EUROPEAN JOURNAL OF RADIOLOGY (2011)
Consensus Criteria for the Use of Magnetic Resonance Imaging in the Diagnosis and Staging of Prostate Cancer: Not Ready for Routine Use
Axel Heidenreich
EUROPEAN UROLOGY (2011)
Randomised prostate cancer screening trial: 20 year follow-up
Gabriel Sandblom et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Prostate cancer mortality in screen and clinically detected prostate cancer: Estimating the screening benefit
Pim J. van Leeuwen et al.
EUROPEAN JOURNAL OF CANCER (2010)
Estimates of cancer incidence and mortality in Europe in 2008
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2010)
A qualitative approach to combined magnetic resonance imaging and spectroscopy in the diagnosis of prostate cancer
Geert M. Villeirs et al.
EUROPEAN JOURNAL OF RADIOLOGY (2010)
Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer
Laurence Klotz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Mortality results from the Goteborg randomised population-based prostate-cancer screening trial
Jonas Hugosson et al.
LANCET ONCOLOGY (2010)
MAGNETIC RESONANCE IMAGING IN DIAGNOSIS, STAGING AND RADIOTHERAPY PLANNING FOR PROSTATE CANCER
G. M. Villeirs et al.
ACTA CLINICA BELGICA (2010)
Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials
Mia Djulbegovic et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Prostate Cancer Mortality Reduction by Prostate-Specific Antigen-Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)
Monique J. Roobol et al.
EUROPEAN UROLOGY (2009)
Prostate Cancer Gene 3 (PCA3): Development and Internal Validation of a Novel Biopsy Nomogram
Felix K. Chun et al.
EUROPEAN UROLOGY (2009)
Outcomes of Localized Prostate Cancer Following Conservative Management
Grace L. Lu-Yao et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
15-Year Followup of a Population Based Prostate Cancer Screening Study
Anders Kiellman et al.
JOURNAL OF UROLOGY (2009)
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Gerald L. Andriole et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Screening and Prostate-Cancer Mortality in a Randomized European Study
Fritz H. Schroeder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Herault
J. Jegu et al.
PROGRES EN UROLOGIE (2009)
Tyrol Prostate Cancer Demonstration Project: Early detection, treatment, outcome, incidence and mortality
Georg Bartsch et al.
BJU INTERNATIONAL (2008)
Detection of prostate cancer in 2007 - Part 1: PSA and PSA kinetics
Fritz H. Schroder et al.
EUROPEAN UROLOGY (2008)
Radical prostatectomy versus watchful waiting in localized prostate cancer:: the Scandinavian Prostate Cancer Group-4 randomized trial
Anna Bill-Axelson et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Interval cancers in prostate cancer screening:: Comparing 2- and 4-year screening intervals in the European randomized study of screening for prostate cancer, Gothenburg and Rotterdam
Monique J. Roobol et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Prostate-specific antigen in the early detection of prostate cancer
Ian M. Thompson et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2007)
Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer - Results from a prospective, population-based randomized controlled trial
Gunnar Aus et al.
EUROPEAN UROLOGY (2007)
Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/mL or lower
IM Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
20-year outcomes following conservative management of clinically localized prostate cancer
PC Albertsen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Clinical consequences of screening for prostate cancer:: 15 years follow-up of a randomised controlled trial in Sweden
G Sandblom et al.
EUROPEAN UROLOGY (2004)
Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter
IM Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Screening decreases prostate cancer mortality:: 11-year follow-up of the 1988 Quebec prospective randomized controlled trial
F Labrie et al.
PROSTATE (2004)
Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut
G Lu-Yao et al.
BMJ-BRITISH MEDICAL JOURNAL (2002)
分享论文
